1. Merck leaps into COVID vaccine race — Evofem Biosciences gets FDA approval for new non-hormonal contraceptive — Sanofi sells $13 billion stake in Regeneron — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

The industry

Discussion in 'Advogent' started by Anonymous, Oct 19, 2007 at 12:39 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    http://dida.library.ucsf.edu/pdf/oha00a10
    This is one of many links re: results of pharma driving a good thing into the ground and essentially 'eating its young.' Involving reps to select attendees, venues, attend and comment, promote etc had a drying effect on the peer meetings business. IMO of course.
     

  2. Anonymous

    Anonymous Guest

    I agree with you on the reps with the attendees, venues, etc. which has ruined the business but it is now the only way that a rep can see a doctor. However, the guy in this link (David Franklin) is all about the money. He was with P-D for a grand total of 4 1/2 months back in 1996 and then waited 6 years to file this. He is simply trying to secure some money as a "whistleblower."
     
  3. #23 Anonymous, Jan 26, 2011 at 1:24 PM
    Last edited by a moderator: Jan 1, 2017 at 9:26 AM
    Anonymous

    Anonymous Guest

    There's a big lag time with these cases. Sometimes they're hidden even from the defendants for like four years while the govt investigates, about 6 years after "filing" is pretty routine. Franklin got the ball rolling in 1996 according to an article in a mag for lawyers http://greenellp.com/news/wp-content/uploads/2010/11/Trial_Sept10_Spotlight.pdf